Obstructive sleep apnoea (OSA), characterized by recurrent periods of upper airway
obstruction and intermittent hypoxaemia, is prevalent in patients with cardiovascular disease …

Sleep apnoea, one of the most common chronic diseases, is a risk factor for ischaemic
stroke, stroke recurrence, and poor functional recovery after stroke. More than half of stroke …

The main aim of this international consensus document on obstructive sleep apnea is to
provide guidelines based on a critical analysis of the latest literature to help health …

Rationale: Randomized controlled trials showed no effect of positive airway pressure (PAP)
therapy for obstructive sleep apnea (OSA) on cardiovascular (CV) risk. However, patient …

Three recent randomized control trials (RCTs) found that treatment of obstructive sleep
apnea (OSA) with continuous positive airway pressure (CPAP) did not reduce rates of future …

El objetivo principal de este documento internacional de consenso sobre apnea obstructiva
del sueño es proporcionar unas directrices que permitan a los profesionales sanitarios …

When considered separately from cardiovascular disease, stroke is the third leading cause
of death in the US and is the leading cause of long-term disability in adults. New approaches …

Abstract Study Objectives Randomized controlled trials (RCTs) have shown no reduction in
adverse cardiovascular (CV) events in patients randomized to continuous positive airway …

Due in part to overall improvements in health, the population of elderly individuals is
increasing rapidly. Similarly, obstructive sleep apnoea (OSA) is both gaining increased …

We aimed to address the impact of OSA and its treatment with continuous positive airway
pressure (CPAP) on major adverse cardiovascular and cerebrovascular events (MACCE) in …